The injectable medication AQUALYXTM contains sodium salts of 12alfa-dihydroxy-5beta-24-oico cholanic acid, a modified form of cholanic acid. It is not a straightforward deoxycholate solution. It is promoted as a "Aqualysis" or "Aquaplasty" procedure for body shaping. This is a kind of intralipotherapy, lipolysis, or injectable lipolysis. It was initially presented in 2009 and was created by Professor Pasquale Motolese, president of the Italian Society of Aesthetics and Medicine. It is occasionally known as "Motolese's Solution." The Italian company Marllor created AQUALYX, which was initially introduced in the UK in 2013. Healthxchange Pharmacy is in charge of distribution in the UK. To treat specific pockets of fat under the skin's surface, AQUALYX was created. Treatment options include the treatment of fat deposits on the back, chin, stomach, buttocks, hips, thighs, and knees. Additionally, it can be used to treat pseudo-gynecomastia, a condition in which a man's nipple develops fatty tissue, giving the appearance of a "breast" (due to weight gain rather than the growth of actual breast tissue as seen in genuine male gynaecomastia). Clinical evidence demonstrates that AQUALYX application is efficient and secure, producing a progressively contoured look.